Charles River Laboratories International (CRL) Cash from Investing Activities Growth (1y) (2010 - 2025)
Charles River Laboratories International (CRL) Cash from Investing Activities Growth (1y) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 465.38% |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | -1,600.38% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -2.89% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | -13.29% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 32.46% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 35.74% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -91.12% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | -480.95% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -353.86% |
| 10 | Charles River Laboratories International | 9.23 Bn | 9.02 Bn | 744.94 Mn | -21.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | -21.95% |
| Sep 27, 2025 | -58.02% |
| Jun 28, 2025 | 39.65% |
| Mar 29, 2025 | 46.99% |
| Dec 28, 2024 | 68.07% |
| Sep 28, 2024 | 73.20% |
| Jun 29, 2024 | 19.24% |
| Mar 30, 2024 | 49.12% |
| Dec 30, 2023 | -637.08% |
| Sep 30, 2023 | 13.70% |
| Jul 1, 2023 | 83.42% |
| Apr 1, 2023 | -72.05% |
| Dec 31, 2022 | 376.88% |
| Sep 24, 2022 | 74.04% |
| Jun 25, 2022 | 51.57% |
| Mar 26, 2022 | 28.98% |
| Dec 25, 2021 | 110.53% |
| Sep 25, 2021 | -401.41% |
| Jun 26, 2021 | -3,233.31% |
| Mar 27, 2021 | 66.64% |